FDA Inspection 1311382 — Gulf Coast Regional Blood Center

Gulf Coast Regional Blood Center — FEI 3003949974

The FDA completed an inspection of Gulf Coast Regional Blood Center on March 31, 2026 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 31, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)